One woman’s remarkable resolve to help give better treatment options for people with rare blood cancers - National
Publish Date: 2/3/2017
A better treatment option for people with the blood cancer myeloproliferative neoplasms (MPN), is one step closer to being made available to Australians, with the new drug interferon alfa-2a (Pegasys®), being discussed at today’s Pharmaceutical Benefits Advisory Committee (PBAC) meeting.
Breakthrough cancer drug venetoclax approved for use in Australia - National
Publish Date: 10/1/2017
New anti-cancer drug, venetoclax which has the power to ‘melt away’ advanced forms of chronic lymphocytic leukaemia (CLL) was recently granted approval by the Australian Therapeutic Goods Administration (TGA).
Do you have a green thumb? Can you spare a few hours a fortnight to do some gardening for the Leukaemia Foundation? The Leukaemia Foundation is seeking volunteers to help maintain the gardens at our Westmead and Waverton accommodation.